Home > Dermatology > AAD 2022 > Posters > Inpatient dermatologic therapy is linked to lower mortality and readmission rates

Inpatient dermatologic therapy is linked to lower mortality and readmission rates

Presented By
Dr Pranav Puri
Conference
AAD 2022
Doi
https://doi.org/10.55788/a6947ffd
Inpatients treated for skin disorders fare better in hospitals that provide specialist dermatologic services. Although the resulting costs are moderately higher, the odds of mortality and re-admission are decreased. In 2014, about 12% of adult patients who were hospitalised in the USA carried the diagnosis of a skin disorder and their in-hospital care was associated with costs of over 5 billion US dollars [1]. Single-centre data showed that dermatologic specialist consultations for inpatients entailed lower numbers of readmission and greater diagnostic precision [2,3]. A retrospective study using Centers for Medicare & Medicaid Services data strove to investigate whether inpatient dermatologic treatment led to superior outcomes [4]. Assessed were more than 30,900 dermatology patients with major and minor skin disorders discharged from 1,912 teaching hospitals in the USA from January 2016 to November 2018. The presence of inpatient dermatology wa...


Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on